Liraglutide

Saxenda, Victoza, NN2211, NN-2211, Xultophy

Forms: Injectable pens: Victoza (type 2 diabetes) and Saxenda (weight management); generic liraglutide from several makers; Xultophy combines it with insulin degludec.

Insulin, GLP-1 & metabolic drugsPrescription onlyEvidence: approved medicine

A GLP-1 receptor agonist and older, shorter-acting relative of semaglutide. Approved for type 2 diabetes and weight management; in the main obesity trial average weight loss was 8.4 kg.

What it gives

What people use it for and what the sources report. Strength is a general category from the literature: mild, clear or strong.

Purpose

Used in sport to cut fat with less hunger, in contest prep or to control appetite; bodybuilders often combine it with anabolic steroids. It lowers weight by reducing food intake, not by speeding up metabolism.

What people seek and what studies show

In a 56-week trial people without diabetes lost 8.4 kg on average vs 2.8 kg on placebo, and 63% lost at least 5% of body weight. In type 2 diabetes with high heart risk it lowered heart attacks, strokes and cardiovascular deaths (13.0% vs 14.9%). With GLP-1 drugs about 20–30% of the weight lost is lean mass, and trials show no consistent gain in physical performance.

Effects

Fat lossLower appetite

Evidence: Approved medicine — studied in people for its medical use

Sought effects by goal (as reported)

Cutting
Sought for: fat loss, lower appetite
Recomposition
Sought for: fat loss
Works against it: muscle loss (catabolism)
Endurance
Sought for: fat loss

Possible side effects

Possible does not mean certain: whether they appear depends on dose, duration, individual response and monitoring. Below — what to watch for and how to notice it early.

8 possible side effects

level · how often it is reported
Elevated
Black-market quality risk (fakes, contamination)
Pharmacy pens are quality-controlled; liraglutide bought outside pharmacies has unverified content and sterility.
How to notice: Unexpected effects, pain or infection, a stronger or weaker effect than expected.
rare
Moderate
Nausea, GI upset, pancreatitis risk
Nausea in about 39% vs 14% on placebo, vomiting 16% vs 4%; gallstones and pancreatitis can occur (severe belly pain needs urgent care). Tell the anesthesiologist before surgery.
How to notice: Nausea, fullness, constipation or diarrhea.
common
Moderate
Muscle loss (catabolism)
Part of the weight lost is lean mass; resistance training and enough protein help keep muscle.
How to notice: Strength and fullness drop despite training.
common
Moderate
Kidney strain
Fluid loss from vomiting or diarrhea can cause acute kidney injury, especially with diuretics or water cutting.
How to notice: Usually silent; foamy urine or swelling in later stages.
rare
Moderate
Abnormal tissue growth (theoretical cancer risk)
Boxed warning: thyroid C-cell tumors in rodents; not for those with (family) medullary thyroid cancer or MEN2. A neck lump or lasting hoarseness needs a doctor.
How to notice: No direct signs — the point is not to fuel existing growths.
rare
Low
Fast heart rate / arrhythmia
Raises resting heart rate by 2–3 beats on average; a rise of over 10 beats occurred in 34% vs 19% on placebo. Adds to stimulants and clenbuterol.
How to notice: Racing heart, skipped beats, shaky hands.
common
Low
Injection pain, infection, oil cough
Injection-site reactions in about 14% vs 11% on placebo.
How to notice: Soreness, lumps; a short coughing fit right after an injection.
possible
Low
Dangerous low blood sugar
Uncommon on its own; the risk rises with insulin or other glucose-lowering drugs, and a bodybuilding-forum study flagged lows when GLP-1 drugs are combined with steroids.
How to notice: Shaking, sweating, sudden hunger, confusion.
rare

What the levels mean

Lowbackground — just be aware
Moderatewatch for signs
Elevatedneeds regular control
Highcritical — can be life-threatening or permanent

Level: general category from the literature, not your personal risk

How often

common
reported often
possible
reported in some people
rare
reported occasionally

How to lower the risks

For 5 of 8 possible side effects there are specific ways to lower the chance: everyday measures, supplements and options a doctor may consider. For the rest — general advice. No measure removes a risk completely.

ElevatedBlack-market quality risk (fakes, contamination)

Products obtained without a prescription are often fake, mislabeled or non-sterile, and there is no way to check at home. For legal supplements, look for third-party testing (Informed Sport, NSF).

ModerateNausea, GI upset, pancreatitis risk

Smaller meals, enough fluid and fiber; a doctor for severe abdominal pain.

Measure
Working with a doctor
Supplement or OTC product
How each option helps (2)
  • Working with a doctor — Assesses persistent vomiting or severe belly pain (possible pancreatitis or gallstones) and adjusts prescribed GLP-1 treatment when nausea persists.
  • Pancreatin + dimeticone (Pankreoflat) — May ease heaviness and gas after meals; can cause nausea or diarrhea. Not for pork or cow's milk protein allergy (anaphylaxis reported) or early acute pancreatitis.
ModerateMuscle loss (catabolism)

Enough protein and calories, keep heavy training, avoid overly aggressive deficits.

How each option helps (2)
  • Essential amino acids (EAA, incl. BCAA) — With low protein intake, may lower the chance of muscle loss by supporting protein synthesis; whole protein works as well, and neither removes the risk of drug-driven catabolism.
  • Whey protein — Enough protein may lower the chance of muscle loss in a calorie deficit; it does not remove the risk, especially with drug-driven catabolism (e.g. thyroid hormone).
ModerateKidney strain

Drink enough water, control blood pressure, avoid regular painkillers (NSAIDs).

Measure
Fluid & electrolyte managementRegular blood testsWorking with a doctor
How each option helps (3)
  • Fluid & electrolyte management — Good hydration eases kidney stress from heavy training and heat; dehydration plus NSAIDs is a classic cause of acute kidney injury.
  • Regular blood tests — Creatinine reads high in muscular people and with creatine; cystatin C and a urine test give a truer picture of the kidneys.
  • Working with a doctor — Investigates protein in the urine or falling kidney function and can start treatment that slows kidney damage.
ModerateAbnormal tissue growth (theoretical cancer risk)

No check-up or blood test lowers this risk; avoid with any personal or family history of cancer.

Low-level side effects

Heart rhythm
Limit caffeine and other stimulants; with palpitations, stop the suspected drug and get an ECG. Don't add potassium on your own (supplements, Asparkam/Panangin, salt substitutes): it is dangerous with spironolactone, ARBs/ACE inhibitors or kidney problems; a blood test shows the level.
Measure
Heart screening: ECG and echocardiogram
How each option helps (1)
  • Heart screening: ECG and echocardiogram — An ECG reveals arrhythmias, conduction problems and QT changes — important with stimulants, clenbuterol, thyroid hormone or diuretics.
Injection site
Sterile technique, never share needles, vials or pens; see a doctor for a hot, swollen site. If equipment was ever shared, test for HIV and hepatitis B/C and ask about hepatitis B vaccination.
Low blood sugar
Never alone, fast sugar always at hand, a glucometer, eat on schedule.
Measure
Glucose monitoringAvoiding alcohol and other liver stressors
How each option helps (2)
  • Glucose monitoring — Readings, fast carbs and company help catch and treat lows — but deaths still occur; there is no safe way to misuse insulin.
  • Avoiding alcohol and other liver stressors — Alcohol blocks the liver's glucose release, making insulin lows deeper and longer, including overnight.

Check-ups and blood tests

Which tests and check-ups to do and when. This is a guide — agree the exact schedule with your doctor.

Baseline tests
your own starting values — every later result is compared with them
Kidney panel (creatinine, eGFR, cystatin C)kidneys
Fasting glucose, insulin, HbA1c
Home blood-pressure logkidneys
Urinalysiskidneys
While taking
about 4–6 weeks in, then every 6–8 weeks — agree the exact schedule with your doctor
Kidney panel (creatinine, eGFR, cystatin C)kidneys
Fasting glucose, insulin, HbA1c
Home blood-pressure logkidneys
Urinalysiskidneys
After stopping
4–8 weeks after stopping (later after long-acting injections), then until values return to baseline
Kidney panel (creatinine, eGFR, cystatin C)kidneys
Fasting glucose, insulin, HbA1c

Which doctors can help

Sports physiciancoordinates everything
Nephrologistkidneys
Gastroenterologist / hepatologistdigestion

Get medical help at once if

  • Much less urine than usual, cola-colored urine, new swelling, flank pain — see a doctor now.
  • Severe upper-abdominal pain spreading to the back, with vomiting (urgent amylase/lipase test); pain under the right ribs with fever or yellow eyes; vomiting with no stool or wind — seek urgent care.
  • A new lump (including in the neck), trouble swallowing or persistent hoarseness, unexplained weight loss, or blood in stool or urine — see a doctor promptly.

In an emergency, call your local emergency number.

For women

Stop when pregnancy is recognized: animal studies showed harm to the fetus. It slows stomach emptying and lowered peak levels of birth-control pills, though total exposure was similar.

Myth & fact

Myth

“Liraglutide speeds up metabolism and burns fat.”

Fact

Per its label it lowers weight by cutting calorie intake and does not raise 24-hour energy expenditure; part of the weight lost is lean mass.

Combinations

Dangerous combinationInsulin with another sugar-lowering substance

Each of these lowers blood sugar in its own way, so with insulin the lows come deeper, last longer and are harder to predict. Confusion, sweating or drowsiness is an emergency; a severe low can kill.

Insulin (rapid- and short-acting)IGF-1 LR3MetforminSemaglutideTirzepatideRetatrutide (investigational triple agonist)BerberineAlpha-lipoic acidCagrilintide (investigational amylin analogue)Mecasermin (recombinant IGF-1, Increlex)DES(1-3) IGF-1
Dangerous combinationIGF-1 LR3 with another sugar-lowering substance

IGF-1 LR3 acts like a long-lasting insulin. Other sugar-lowering substances add to it, so lows come deeper and last longer; confusion, sweating or drowsiness is an emergency.

IGF-1 LR3MetforminSemaglutideTirzepatideRetatrutide (investigational triple agonist)BerberineAlpha-lipoic acidCagrilintide (investigational amylin analogue)Mecasermin (recombinant IGF-1, Increlex)DES(1-3) IGF-1
CautionGlucocorticoid with insulin, IGF-1 or a GLP-1 drug

Glucocorticoids raise blood sugar, after a depot injection often for days, and work against insulin, IGF-1 and GLP-1 drugs. Sugar can run high while the glucocorticoid acts and then fall as its effect wears off while the sugar-lowering drug keeps working. Only glucose checks show these swings.

Insulin (rapid- and short-acting)IGF-1 LR3Mecasermin (recombinant IGF-1, Increlex)DES(1-3) IGF-1SemaglutideTirzepatideRetatrutide (investigational triple agonist)
Dangerous combinationIGF-1 with another sugar-lowering substance

Mecasermin and DES(1-3) IGF-1 lower blood sugar much like insulin. Other sugar-lowering substances add to them, so lows come deeper and last longer; confusion, sweating or drowsiness is an emergency.

MetforminSemaglutideTirzepatideRetatrutide (investigational triple agonist)Cagrilintide (investigational amylin analogue)BerberineAlpha-lipoic acid

Check combinations →

Similar substances